Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Gerhard

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 11, 2008
Bias: considerations for research practiceTobias Gerhard
Journal of Medical Ethics|June 8, 2021
Do coronavirus vaccine challenge trials have a distinctive generalisability problem?Nir Eyal, Tobias Gerhard
Pharmacoepidemiology and Drug Safety|March 17, 2022
Pandemic vaccine testing: Combining conventional and challenge studiesTobias Gerhard, Brian L Strom, Nir Eyal
Journal of Child and Adolescent Psychopharmacology|April 15, 2009
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorderChih-Ying Chen, Tobias Gerhard, Almut G Winterstein
Journal of the American Veterinary Medical Association|July 4, 2007
Outcomes of nonsurgical management and efficacy of demecarium bromide treatment for primary lens instability in dogs: 34 cases (1990-2004)Daniel R Binder, Ian P Herring, Tobias Gerhard
Journal of the American Academy of Child and Adolescent Psychiatry|March 11, 2010
Trends in antipsychotic drug use by very young, privately insured childrenMark Olfson, Stephen Crystal, Cecilia Huang, et al.
Pediatrics|June 6, 2020
Benzodiazepine Treatment and Fracture Risk in Young Persons With Anxiety DisordersGreta A Bushnell, Tobias Gerhard, Stephen Crystal, et al.
Journal of Clinical Psychopharmacology|February 2, 2026
The Use of VMAT2 Inhibitors for Tardive DyskinesiaOrges Alabaku, Mark Olfson, T Scott Stroup, et al.
Pediatrics|July 1, 2009
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHDAlmut Gertrud Winterstein, Tobias Gerhard, Jonathan Shuster, et al.
Pharmacoepidemiology and Drug Safety|September 1, 2017
Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulationDaniel B Horton, Tobias Gerhard, Amy Davidow, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 11, 2008
Bias: considerations for research practiceTobias Gerhard
Journal of Medical Ethics|June 8, 2021
Do coronavirus vaccine challenge trials have a distinctive generalisability problem?Nir Eyal, Tobias Gerhard
Pharmacoepidemiology and Drug Safety|March 17, 2022
Pandemic vaccine testing: Combining conventional and challenge studiesTobias Gerhard, Brian L Strom, Nir Eyal
Journal of Child and Adolescent Psychopharmacology|April 15, 2009
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorderChih-Ying Chen, Tobias Gerhard, Almut G Winterstein
Journal of the American Veterinary Medical Association|July 4, 2007
Outcomes of nonsurgical management and efficacy of demecarium bromide treatment for primary lens instability in dogs: 34 cases (1990-2004)Daniel R Binder, Ian P Herring, Tobias Gerhard
Journal of the American Academy of Child and Adolescent Psychiatry|March 11, 2010
Trends in antipsychotic drug use by very young, privately insured childrenMark Olfson, Stephen Crystal, Cecilia Huang, et al.
Pediatrics|June 6, 2020
Benzodiazepine Treatment and Fracture Risk in Young Persons With Anxiety DisordersGreta A Bushnell, Tobias Gerhard, Stephen Crystal, et al.
Journal of Clinical Psychopharmacology|February 2, 2026
The Use of VMAT2 Inhibitors for Tardive DyskinesiaOrges Alabaku, Mark Olfson, T Scott Stroup, et al.
Pediatrics|July 1, 2009
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHDAlmut Gertrud Winterstein, Tobias Gerhard, Jonathan Shuster, et al.
Pharmacoepidemiology and Drug Safety|September 1, 2017
Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulationDaniel B Horton, Tobias Gerhard, Amy Davidow, et al.
Pageof 10